Wave Life Sciences Ltd.
HealthcareNASDAQ:WVE · NASDAQ Global Market
+$0.06 today
Vol 2.24M · Avg 4.85M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-15.54%
Period High
$21.31
Period Low
$5.66
Latest
$5.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Spyre Therapeutics, Inc.
NASDAQ:SYRE
$4.88B
Terns Pharmaceuticals, Inc.
TERN
$4.77B
Enliven Therapeutics, Inc.
NASDAQ:ELVN
$2.81B
Intellia Therapeutics, Inc.
NASDAQ:NTLA
$1.36B
Precigen, Inc.
NASDAQ:PGEN
$1.34B
Tourmaline Bio, Inc.
TRML
$1.23B
Amylyx Pharmaceuticals, Inc.
NASDAQ:AMLX
$1.21B
Zenas BioPharma, Inc.
NASDAQ:ZBIO
$883.93M
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$856.09M
Upstream Bio, Inc.
UPB
$331.96M
What is the latest WVE filing?
The latest filing shown is 8-K dated May 18, 2026.
How many recent filings does WVE have?
Intrinsic Alpha currently shows 20 recent filings for WVE.
Explore More
Continue the stock analysis
Jump to another research area for this company.